In a recent study published in the journal PLOS Currents, a team of researchers from Cambridge in…
Articles by Ana de Barros, PhD
The New York Blood Center (NYBC) and the Howard and Abby Milstein Foundation recently announced plans to expand their partnership and…
Cloud-based drug design and development company, Cloud Pharmaceuticals, Inc., recently announced it has signed with THERAMetrics holding AG to collaborate on…
A team of scientists at the University of Louisville are determined to find out if a promising treatment, VX15, an…
Sangamo BioSciences, Inc., a leader in therapeutic genome editing, recently announced it has agreed to amend its January 2012 collaboration and…
Evotec AG announced the CHDI Foundation, Inc. has agreed to extend and expand its partnership with the company until August…
The New York Blood Center (NYBC), one of the largest independent, community-based blood centers in the country, serving the more…
In a recent study published in the journal Scientific Reports, researchers showed that a new test developed…
A groundbreaking research initiative on cell reprogramming for drug development against Huntington’s disease recently received $1.19 million worth of funding…
Isis Pharmaceuticals, Inc. a leading company in RNA-targeted drug discovery and development, recently announced they will initiate a new Phase I/IIa…